Products for Research Use Only
RegisterLogin

SRT6

CAT: 0804-HY-175809Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175809Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SRT6, an anticancer agent is a CD44 inhibitor. SRT6 inhibits key CD44-associated kinases, including SRC, ERBB2 and MAPKAPK2. SRT6 has strong tumor selectivity over non-tumoral lung cells and significant antiproliferative activity against cancer cells (EC50of 1.37 μM for NCI-H23 cells) [1].
UNSPSC
12352005
Target
CD44; EGFR; MAPKAPK2 (MK2) ; Src
Related Pathways
Immunology/Inflammation; JAK/STAT Signaling; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=S(C1=CC=C([N+]([O-])=O)C=C1)(OC2=CC=CC3=C2CCN(CC4=CC(OC)=C(OC)C(OC)=C4)C3)=O
Molecular Formula
C25H26N2O8S
Molecular Weight
514.55
References & Citations
[1]Romero-Tamudo S, et al. CD44-targeted N-benzyltetrahydroisoquinoline derivatives as anticancer agents with high tumor-to-normal cell selectivity. Eur J Med Chem. 2025 Nov 15;298:118039.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-161124SrtA-IN-2
HY-173219SrtA-IN-1
HY-10532-01SRT 1720
HY-15262-01SRT 2104
HY-124037-01SRT 1460
HY-19759-01SRT 2183
HY-P703434-01SrtA, Staphylococcus aureus (His)
HY-P703433-01SrtA Protein, S. aureus
HY-10532R-01SRT 1720 (Standard)
HY-15145A-01SRT 1720 (dihydrochloride)

Alternative Products

CatalogName
GTR19273099-01SRT6

Popular Products